KDM2B and breast cancer: Considering that FBXL10 was dysregulated in some types of solid tumors, bioinformatics analysis using UALCAN dataset (http://ualcan.path.uab.edu/) was conducted based on The Cancer Genome Atlas (TCGA) to determine the expression of FBXL10 in breast cancer [46].